Dolzhenko, Egor http://orcid.org/0000-0002-3296-0677
Weisburd, Ben
IbaƱez, Kristina
Rajan-Babu, Indhu-Shree
Anyansi, Christine
Bennett, Mark F.
Billingsley, Kimberley
Carroll, Ashley
Clamons, Samuel
Danzi, Matt C.
Deshpande, Viraj
Ding, Jinhui
Fazal, Sarah
Halman, Andreas
Jadhav, Bharati
Qiu, Yunjiang
Richmond, Phillip A.
Saunders, Christopher T.
Scheffler, Konrad
van Vugt, Joke J. F. A.
Zwamborn, Ramona R. A. J.
,
Chong, Samuel S.
Friedman, Jan M.
Tucci, Arianna
Rehm, Heidi L.
Eberle, Michael A.
Funding for this research was provided by:
None
Article History
Received: 20 October 2021
Accepted: 11 July 2022
First Online: 11 August 2022
Declarations
:
: Following ethical approval from the national research ethics committee (14/EE/1112), consent was obtained from all patients recruited to the 100,000 Genomes Project (reference: doi: 10.1056/NEJMoa2035790). The research conformed to the principles of the Helsinki Declaration.
: Not applicable.
: ED, CA, AC, SC, VD, YQ, CS, KS, and ME are or were employees of Illumina, Inc., and HR has received funding from Illumina, Inc., a public company that develops and markets systems for genetic analysis. The other authors declare that they have no competing interests.